Literature DB >> 16178416

Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge.

Song-Yi Lee1, Doo-Youn Choi, Eun-Rhan Woo.   

Abstract

We screened natural products to find compounds with anti-osteoporotic potential using a coculture-based system by which osteoclast differentiation is effectively achieved. We found that methylene chloride soluble fraction of the root of Salvia miltiorrhiza Bunge (Labiatae) suppressed osteoclast differentiation. Five tanshinones, tanshinone IIA (1), tanshinone 1 (2), cryptotanshinone (3), 15,16-dihydrotanshinone I (4), and ferruginol (5) were subsequently isolated from fraction. Among the five compounds, compounds 1-4 reduced the formation of TRAP-positive multinuclear osteoclasts. These results suggest that the identified tanshinones may be useful candidates for development of therapeutic agents to treat osteoporosis and other bone-resorptive diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178416     DOI: 10.1007/BF02973876

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  18 in total

1.  Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.

Authors:  Yintao Ye; Wenqing Xu; Wei Zhong; Yajing Li; Chen Wang
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone.

Authors:  Preety Panwar; Simon Law; Andrew Jamroz; Pouya Azizi; Dongwei Zhang; Marco Ciufolini; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2018-02-09       Impact factor: 8.739

3.  Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats.

Authors:  Liao Cui; Yu-Yu Liu; Tie Wu; Chun-Mei Ai; Huai-Qing Chen
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

4.  The NCI library of traditional Chinese medicinal plant extracts - Preliminary assessment of the NCI-60 activity and chemical profiling of selected species.

Authors:  Min He; Tanja Grkovic; Jason R Evans; Christopher C Thornburg; Rhone K Akee; Jerell R Thompson; James A Whitt; Matthew J Harris; Jasmine A Loyal; John R Britt; Libin Jia; Jeffrey D White; David J Newman; Barry R O'Keefe
Journal:  Fitoterapia       Date:  2019-08-03       Impact factor: 2.882

5.  Inhibition of bone resorption by Tanshinone VI isolated from Salvia miltiorrhiza Bunge.

Authors:  V Nicolin; F Dal Piaz; S L Nori; P Narducci; N De Tommasi
Journal:  Eur J Histochem       Date:  2010-05-10       Impact factor: 3.188

6.  Distal-less homeobox 5 is a master regulator of the osteogenesis of human mesenchymal stem cells.

Authors:  June Seok Heo; Seung Gwan Lee; Hyun Ok Kim
Journal:  Int J Mol Med       Date:  2017-09-19       Impact factor: 4.101

7.  Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities.

Authors:  Jianglin Zhao; Jingfeng Lou; Yan Mou; Peiqin Li; Jianyong Wu; Ligang Zhou
Journal:  Molecules       Date:  2011-03-07       Impact factor: 4.411

8.  Antihypertension Induced by Tanshinone IIA Isolated from the Roots of Salvia miltiorrhiza.

Authors:  Paul Chan; I-Min Liu; Ying-Xiao Li; Wen-Jen Yu; Juei-Tang Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-04       Impact factor: 2.629

Review 9.  Recent insights into the biological activities and drug delivery systems of tanshinones.

Authors:  Yuee Cai; Wenji Zhang; Zirong Chen; Zhi Shi; Chengwei He; Meiwan Chen
Journal:  Int J Nanomedicine       Date:  2016-01-05

Review 10.  Protective Effects of Selected Botanical Agents on Bone.

Authors:  James Jam Jolly; Kok-Yong Chin; Ekram Alias; Kien Hui Chua; Ima Nirwana Soelaiman
Journal:  Int J Environ Res Public Health       Date:  2018-05-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.